Ambu A/S (OTCMKTS:AMBBY) Shares Gap Up – What’s Next?
by Danessa Lincoln · The Markets DailyAmbu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) gapped up prior to trading on Wednesday. The stock had previously closed at $10.2250, but opened at $11.64. Ambu A/S shares last traded at $11.64, with a volume of 100 shares traded.
Analyst Upgrades and Downgrades
Separately, UBS Group downgraded shares of Ambu A/S from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 15th. One research analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the stock has an average rating of “Hold”.
Read Our Latest Stock Report on AMBBY
Ambu A/S Price Performance
The company has a debt-to-equity ratio of 0.08, a current ratio of 2.77 and a quick ratio of 1.69. The firm has a 50-day moving average of $10.88 and a 200-day moving average of $10.39. The stock has a market cap of $2.74 billion, a PE ratio of 38.80 and a beta of 0.92.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its quarterly earnings results on Tuesday, August 25th. The company reported $0.09 EPS for the quarter. Ambu A/S had a return on equity of 8.49% and a net margin of 8.18%. The company had revenue of $255.12 million for the quarter.
Ambu A/S Company Profile
Ambu A/S is a Danish medical device company that develops, manufactures and markets single-use products for hospitals, clinics and emergency care providers. Its portfolio includes disposable endoscopes and visualization systems used in areas such as bronchoscopy, gastrointestinal procedures, urology, ear, nose and throat care, and anesthesia.
The company also supplies products for airway management, patient monitoring and emergency care, including electrodes, resuscitation equipment and training manikins.